| For: | Weiss KH, Merle U, Schaefer M, Ferenci P, Fullekrug J, Stremmel W. Copper toxicosis gene MURR1 is not changed in Wilson disease patients with normal blood ceruloplasmin levels. World J Gastroenterol 2006; 12(14): 2239-2242 [PMID: 16610028 DOI: 10.3748/wjg.v12.i14.2239] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i14/2239.htm |
| Number | Citing Articles |
| 1 |
Michelle Angela Camarata, Si Houn Hahn. Wilson Disease. 2019; doi: 10.1016/B978-0-12-811077-5.00009-8
|
| 2 |
Madhuri Behari, Vibhor Pardasani. Genetics of Wilsons disease. Parkinsonism & Related Disorders 2010; 16(10) doi: 10.1016/j.parkreldis.2010.07.007
|
| 3 |
Karl Heinz Weiss, Daniel Nils Gotthardt, Daniela Klemm, Uta Merle, Daniela Ferenci–Foerster, Mark Schaefer, Peter Ferenci, Wolfgang Stremmel. Zinc Monotherapy Is Not as Effective as Chelating Agents in Treatment of Wilson Disease. Gastroenterology 2011; 140(4) doi: 10.1053/j.gastro.2010.12.034
|
| 4 |
Ralf Weiskirchen, Louis C. Penning. COMMD1, a multi-potent intracellular protein involved in copper homeostasis, protein trafficking, inflammation, and cancer. Journal of Trace Elements in Medicine and Biology 2021; 65 doi: 10.1016/j.jtemb.2021.126712
|
| 5 |
. 2011; doi: 10.70675/526f4178zb1f6z4af1z99c6z46bbfdf31b99
|
| 6 |
Karl Heinz Weiss, Florentine Thurik, Daniel Nils Gotthardt, Mark Schäfer, Ulrike Teufel, Franziska Wiegand, Uta Merle, Daniela Ferenci–Foerster, Andreas Maieron, Rudolf Stauber, Heinz Zoller, Hartmut H. Schmidt, Ulrike Reuner, Harald Hefter, Jean Marc Trocello, Roderick H.J. Houwen, Peter Ferenci, Wolfgang Stremmel. Efficacy and Safety of Oral Chelators in Treatment of Patients With Wilson Disease. Clinical Gastroenterology and Hepatology 2013; 11(8) doi: 10.1016/j.cgh.2013.03.012
|
| 7 |
Bibudhendra Sarkar, Eve A. Roberts. The puzzle posed by COMMD1, a newly discovered protein binding Cu(ii). Metallomics 2011; 3(1) doi: 10.1039/C0MT00031K
|
| 8 |
Alberto Quaglia, Eve A. Roberts, Michael Torbenson. Macsween's Pathology of the Liver. 2018; doi: 10.1016/B978-0-7020-6697-9.00003-0
|
| 9 |
Clavia Ruth Wooton-Kee. Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease. Pharmacology & Therapeutics 2023; 251 doi: 10.1016/j.pharmthera.2023.108529
|
| 10 |
Tomasz Litwin, Anna Członkowska. Choroba Wilsona – czynniki wpływające na obraz kliniczny. Neurologia i Neurochirurgia Polska 2013; 47(2) doi: 10.5114/ninp.2013.34397
|
| 11 |
|
| 12 |
Mario Riera‐Romo. COMMD1: A Multifunctional Regulatory Protein. Journal of Cellular Biochemistry 2018; 119(1) doi: 10.1002/jcb.26151
|
| 13 |
Grażyna Gromadzka, Magdalena Rudnicka, Grzegorz Chabik, Adam Przybyłkowski, Anna Członkowska. Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson’s disease. Journal of Hepatology 2011; 55(4) doi: 10.1016/j.jhep.2011.01.030
|
| 14 |
Willianne IM Vonk, Cisca Wijmenga, Bart van de Sluis. Relevance of animal models for understanding mammalian copper homeostasis. The American Journal of Clinical Nutrition 2008; 88(3) doi: 10.1093/ajcn/88.3.840S
|
| 15 |
Scott Fink, Michael L Schilsky. Inherited metabolic disease of the liver. Current Opinion in Gastroenterology 2007; 23(3) doi: 10.1097/MOG.0b013e3280ef68e4
|
| 16 |
Karl Heinz Weiss, Mark Schäfer, Daniel Nils Gotthardt, Alexandra Angerer, Carolin Mogler, Peter Schirmacher, Peter Schemmer, Wolfgang Stremmel, Peter Sauer. Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease. Clinical Transplantation 2013; 27(6) doi: 10.1111/ctr.12259
|
| 17 |
Bart van de Sluis. Clinical and Translational Perspectives on WILSON DISEASE. 2019; doi: 10.1016/B978-0-12-810532-0.00007-0
|
| 18 |
Karl Heinz Weiss, Wolfgang Stremmel. Evolving Perspectives in Wilson Disease: Diagnosis, Treatment and Monitoring. Current Gastroenterology Reports 2012; 14(1) doi: 10.1007/s11894-011-0227-3
|
| 19 |
|
| 20 |
|
| 21 |
Louis C. Penning, Marina Berenguer, Anna Czlonkowska, Kay L. Double, Petr Dusek, Carmen Espinós, Svetlana Lutsenko, Valentina Medici, Wiebke Papenthin, Wolfgang Stremmel, Jose Willemse, Ralf Weiskirchen. A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020420
|
| 22 |
Emilie Glavind, Daniel N. Gotthardt, Jan Pfeiffenberger, Thomas Damgaard Sandahl, Teodora Bashlekova, Gro Linno Willemoe, Jane Preuss Hasselby, Karl Heinz Weiss, Holger Jon Møller, Hendrik Vilstrup, William M. Lee, Michael L. Schilsky, Peter Ott, Henning Grønbæk. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease. Orphanet Journal of Rare Diseases 2020; 15(1) doi: 10.1186/s13023-020-01452-2
|
| 23 |
Karl Heinz Weiss, Heiko Runz, Barbara Noe, Daniel Nils Gotthardt, Uta Merle, Peter Ferenci, Wolfgang Stremmel, Joachim Füllekrug. Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease. Journal of Inherited Metabolic Disease 2010; 33(S3) doi: 10.1007/s10545-010-9123-5
|
| 24 |
Eve A. Roberts, Calvin H.F. Lau, Themis Reverbel da Silveira, Suyun Yang. Developmental expression of Commd1 in the liver of the Jackson toxic milk mouse. Biochemical and Biophysical Research Communications 2007; 363(4) doi: 10.1016/j.bbrc.2007.09.059
|
| 25 |
Richard J. Thompson, Bernard C. Portmann, Eve A. Roberts. MacSween's Pathology of the Liver. 2012; doi: 10.1016/B978-0-7020-3398-8.00004-0
|
| 26 |
Hille Fieten, Peter A. J. Leegwater, Adrian L. Watson, Jan Rothuizen. Canine models of copper toxicosis for understanding mammalian copper metabolism. Mammalian Genome 2012; 23(1-2) doi: 10.1007/s00335-011-9378-7
|
| 27 |
A. E. Postrigan, I. Zh. Zhalsanova, E. A. Fonova, N. A. Skryabin. Modifier Genes as a Cause of Wilson–Konovalov Disease Clinical Polymorphism. Russian Journal of Genetics 2021; 57(5) doi: 10.1134/S1022795421050094
|
| 28 |
Arnab Gupta, Ishita Chattopadhyay, Shashwata Mukherjee, Mainak Sengupta, Shyamal K Das, Kunal Ray. A novel COMMD1 mutation Thr174Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson Disease patient. Behavioral and Brain Functions 2010; 6(1) doi: 10.1186/1744-9081-6-33
|
| 29 |
T. Litwin, G. Gromadzka, J. Samochowiec, A. Grzywacz, A. Członkowski, A. Członkowska. JIMD Reports - Case and Research Reports, 2012/5. JIMD Reports 2012; 8 doi: 10.1007/8904_2012_163
|
| 30 |
Ana Sánchez-Monteagudo, Edna Ripollés, Marina Berenguer, Carmen Espinós. Wilson’s Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines 2021; 9(9) doi: 10.3390/biomedicines9091100
|
| 31 |
Karolina Dzieżyc, Tomasz Litwin, Grzegorz Chabik, Karolina Gramza, Anna Członkowska. Families with Wilson's disease in subsequent generations: Clinical and genetic analysis. Movement Disorders 2014; 29(14) doi: 10.1002/mds.26057
|
| 32 |
A Zarina, I Tolmane, Z Krumina, AI Tutane, L Gailite. Association of variants in the CP, ATOX1 and COMMD1 genes with Wilson disease symptoms in Latvia. Balkan Journal of Medical Genetics 2019; 22(2) doi: 10.2478/bjmg-2019-0023
|
| 33 |
Prim de Bie, Bart van de Sluis, Ezra Burstein, Peter V.E. van de Berghe, Patricia Muller, Ruud Berger, Jonathan D. Gitlin, Cisca Wijmenga, Leo W.J. Klomp. Distinct Wilson’s Disease Mutations in ATP7B Are Associated With Enhanced Binding to COMMD1 and Reduced Stability of ATP7B. Gastroenterology 2007; 133(4) doi: 10.1053/j.gastro.2007.07.020
|
| 34 |
Dorothy A. Kieffer, Valentina Medici. Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidence. Liver Research 2017; 1(2) doi: 10.1016/j.livres.2017.08.003
|
| 35 |
Alberto Quaglia, Eve A. Roberts, Michael Torbenson. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00003-X
|
| 36 |
P de Bie, P Muller, C Wijmenga, L W J Klomp. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. Journal of Medical Genetics 2007; 44(11) doi: 10.1136/jmg.2007.052746
|